Dr. Mitchell

Edith P. Mitchell, MD, FACP

Contact Dr. Mitchell

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874
(215) 503-9506 fax

Most Recent Peer-reviewed Publications

  1. Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers
  2. Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)
  3. Trametinib activity in patients with solid tumors and lymphomas harboring braf non-V600 mutations or fusions: Results from NCI-MATCH (EAY131)
  4. Corona Virus: Global Pandemic Causing World-Wide Shutdown
  5. 2020 Vision: Continuing Declines in Cancer Incidence and Mortality Rates
  6. Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study
  7. Racial Disparities in Rates of Surgery for Esophageal Cancer: a Study from the National Cancer Database
  8. Attacking Cancer Death Rates
  9. Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q
  10. The National Medical Association: Moving Forward to Eliminate Healthcare Disparities but Keeping Watch Through the Rear View Mirror
  11. Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients
  12. Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome
  13. MAVERICC, a randomized, biomarker-stratified, phase II study of mFOLFOX6-Bevacizumab versus FOLFIRI-bevacizumab as first-line chemotherapy in metastatic colorectal cancer
  14. Loss of nuclear localized parathyroid hormone-related protein in primary breast cancer predicts poor clinical outcome and correlates with suppressed STAT5 signaling
  15. Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials
  16. Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
  17. The Violence Epidemic in the African American Community: A Call by the National Medical Association for Comprehensive Reform
  18. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer
  19. A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group
  20. Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)